YD Bio (YDESW) Inventory Average (2025 - 2026)
YD Bio's (YDESW) quarterly Inventory Average came in at $1.9 million in Q2 2026, up 818.06% year-over-year from $205426.5 in Q2 2025, and up 67.41% quarter-over-quarter from $1.1 million in Q4 2025.
Powered by 
Analysis
YD Bio (YDESW) Inventory Average (2025 - 2026) Analysis & Trends
YD Bio (YDESW) has reported Inventory Average for 2 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Inventory Average rose 818.06% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $1.9 million, a 818.06% increase from a year earlier, with the FY2025 full-year figure at $958438.5, changed N/A from the prior year.
- Inventory Average was $1.9 million for Q2 2026 at YD Bio, up from $1.1 million in the prior quarter.
- Over five years, Inventory Average peaked at $1.9 million in Q2 2026 and troughed at $205426.5 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.05 Bn | 198.06 Bn | 7.24 Bn | 6.20 Bn |
| 2 | Gilead Sciences | 181.76 Bn | 178.58 Bn | 6.22 Bn | 1.93 Bn |
| 3 | Vertex Pharmaceuticals | 132.46 Bn | 124.61 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 82.66 Bn | 74.67 Bn | 3.93 Bn | 3.09 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.37 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.69 Bn | 49.56 Bn | 52.00 Mn | 213.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Biogen | 31.46 Bn | 30.17 Bn | 1.96 Bn | 2.17 Bn |
| 9 | Roivant Sciences | 30.15 Bn | 30.15 Bn | 1.16 Mn | - |
| 10 | YD Bio | 29.02 Mn | 26.36 Mn | - | 1.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.89 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Jun 30, 2025 | 205,426.50 |